Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Vireo Growth ( (TSE:VREO) ) is now available.
Vireo Growth Inc., a cannabis operator with a national portfolio and strong local market focus, is expanding its platform by managing and acquiring additional retail assets in Colorado. The company emphasizes disciplined execution, strategic capital deployment, and long-term value creation for its stakeholders.
Vireo announced that its Management Services Agreement with PharmaCann Inc. became effective on March 22, 2026, enabling it to manage certain PharmaCann Colorado retail assets ahead of an expected asset acquisition closing in the second quarter of 2026, pending regulatory approval. In connection with the transaction, Vireo placed 90,740,741 subordinate voting shares into escrow, underscoring its commitment to the Colorado expansion and deepening its operational footprint in that market.
More about Vireo Growth
Vireo Growth Inc. is a U.S.-based cannabis company founded in 2014 that began as a pioneering medical cannabis operator. It is building a disciplined, execution-focused platform with a strong local market focus while leveraging a national portfolio, deploying capital and talent where it sees the greatest value for customers, employees, shareholders, and partner communities.
YTD Price Performance: -38.55%
Average Trading Volume: 43,264
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$551M
Find detailed analytics on VREO stock on TipRanks’ Stock Analysis page.